Q
28.78
0.22 (0.77%)
| 前收盘价格 | 28.56 |
| 收盘价格 | 28.86 |
| 成交量 | 473,602 |
| 平均成交量 (3个月) | 1,238,180 |
| 市值 | 1,955,069,696 |
| 预期市盈率 (P/E Forward) | 12.36 |
| 价格/销量 (P/S) | 0.810 |
| 股市价格/股市净资产 (P/B) | 1.09 |
| 52周波幅 | |
| 利润日期 | 5 Nov 2025 |
| 营业毛利率 | -12.97% |
| 营业利益率 (TTM) | 7.03% |
| 稀释每股收益 (EPS TTM) | -5.23 |
| 季度收入增长率 (YOY) | -2.60% |
| 总债务/股东权益 (D/E MRQ) | 90.01% |
| 流动比率 (MRQ) | 1.20 |
| 营业现金流 (OCF TTM) | 149.30 M |
| 杠杆自由现金流 (LFCF TTM) | 297.44 M |
| 资产报酬率 (ROA TTM) | 1.12% |
| 股东权益报酬率 (ROE TTM) | -11.38% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | QuidelOrtho Corporation | 看涨 | 看跌 |
AIStockmoo 评分
-0.4
| 分析师共识 | -1.5 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | -0.38 |
|
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 0.92% |
| 机构持股比例 | 112.82% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 35.00 (UBS, 21.61%) | 保留 |
| 中 | 28.50 (-0.97%) | |
| 低 | 22.00 (JP Morgan, -23.56%) | 卖出 |
| 平均值 | 28.50 (-0.97%) | |
| 总计 | 1 保留, 1 卖出 | |
| 平均价格@调整类型 | 24.54 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| UBS | 21 Jan 2026 | 35.00 (21.61%) | 保留 | 28.74 |
| 06 Nov 2025 | 31.00 (7.71%) | 保留 | 21.26 | |
| JP Morgan | 07 Nov 2025 | 22.00 (-23.56%) | 卖出 | 20.35 |
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 21 Jan 2026 | 公告 | QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results |
| 18 Dec 2025 | 公告 | Innovating Diagnostics and What's Next |
| 24 Nov 2025 | 公告 | QuidelOrtho To Participate In Upcoming Investor Conferences |
| 20 Nov 2025 | 公告 | The Power of Prevention: Detecting Diabetes Before It Strikes |
| 05 Nov 2025 | 公告 | QuidelOrtho Reports Third Quarter 2025 Financial Results |
| 03 Nov 2025 | 公告 | QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay |
| 23 Oct 2025 | 公告 | Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics |
| 22 Oct 2025 | 公告 | QuidelOrtho to Report Third Quarter 2025 Financial Results |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合